Answers are grounded in this paper and cite their sources.
BRAF(V600E) in PTC predicts an increased risk of lymph node metastasis, extra-thyroidal extension and reduced disease-free survival. It is an additional useful prognostic biomarker.
No takes yet. Share an insight, caveat, or question.
Fraser et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: